Dev Anant Pharmaceutical Private Limited
About Dev Anant Pharmaceutical Private Limited
Data last updated:
Dev Anant Pharmaceutical Private Limited is a private limited company based in Meerut, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 13 August 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24110UP2020PTC132637. Its GSTIN is 09AAHCD9064D1ZI (Uttar Pradesh).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Munesh Kumar Sharma and Gaurav Kumar Sharma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H 283/4 Ganga Nagar Near Dadhichi Public School, Meerut, Uttar Pradesh, India – 250001.
As per the financials filed for FY 2024, the company reported a revenue of ₹5.61 Lakh, a growth of 88% compared to the previous year. For the same year it recorded a net profit of ₹3,909 (net margin 0.7%) and EBITDA of ₹19,923 (EBITDA margin 3.6%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressH 283/4 Ganga Nagar Near Dadhichi Public School, Meerut, Uttar Pradesh, India – 250001
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Dev Anant Pharmaceutical Private Limited
The main business activity of Dev Anant Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Dev Anant Pharmaceutical Private Limited FY 2025 filings available
Dev Anant Pharmaceutical Private Limited reported revenue of ₹5.61 Lakh (up 88% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Dev Anant Pharmaceutical Private Limited
Revenue rose 88% in the latest year. EBITDA rose 118% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Dev Anant Pharmaceutical Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• |
| EBITDA | ₹19,923 | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹3,909 | •••• | •••• | •••• |
| Balance Sheet | ||||
| Share Capital | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• |
Financial Ratios of Dev Anant Pharmaceutical Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 3.6% | •••• | •••• | •••• |
| Net Profit Margin | 0.7% | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• |
| Liquidity and Debt | ||||
| Current Ratio | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• |
| Efficiency and Growth | ||||
| Asset Turnover | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Dev Anant Pharmaceutical are in the company report.
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Dev Anant Pharmaceutical Private Limited
Dev Anant Pharmaceutical Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale Trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Superlite Vinimay Private Limited | ₹5.61 Lakh (FY 2025) | •••• | •••• | 34.0% | •••• | Kolkata, West Bengal, India |
| Kevin Biotech Private Limited | ₹5.61 Lakh (FY 2020) | •••• | •••• | -58.0% | •••• | Ahmedabad, Gujarat, India |
| Palindrome Design India Private Limited | ₹5.61 Lakh (FY 2024) | •••• | •••• | 97.0% | •••• | New Delhi, Delhi, India |
| Luckwin Trademart Private Limited | ₹5.61 Lakh (FY 2021) | •••• | •••• | •••• | Moradabad, Uttar Pradesh, India | |
| Dev Anant Pharmaceutical Private Limited this company | ₹5.61 Lakh (FY 2024) | •••• | •••• | 88.0% | •••• | Meerut, Uttar Pradesh, India |
| Udhaarlo Private Limited | ₹5.61 Lakh (FY 2023) | •••• | •••• | •••• | Aurangabad, Maharashtra, India | |
| Cyniaris Healthcare Private Limited | ₹5.61 Lakh (FY 2021) | •••• | •••• | -64.0% | •••• | Aurangabad, Maharashtra, India |
| Kasaya Healthcare Private Limited | ₹5.61 Lakh (FY 2025) | •••• | •••• | 72.0% | •••• | Mumbai, Maharashtra, India |
| Indermani Coal Benefication Private Limited | ₹5.61 Lakh (FY 2024) | •••• | •••• | -99.0% | •••• | Raipur, Chhattisgarh, India |
| Tangible Traders Private Limited | ₹5.61 Lakh (FY 2025) | •••• | •••• | 34.0% | •••• | Kolkata, West Bengal, India |
| Subro-Debro Global Private Limited | ₹5.61 Lakh (FY 2024) | •••• | •••• | 132.0% | •••• | Noapara, West Bengal, India |
Peers are the five companies nearest above and the five nearest below Dev Anant Pharmaceutical by revenue in the same principal business activity (Wholesale Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Dev Anant Pharmaceutical Private Limited
Dev Anant Pharmaceutical has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Munesh Kumar Sharma | Director | 13 Aug 2020 | 6 Years 1 Months | Current |
| Gaurav Kumar Sharma | Director | 13 Aug 2020 | 6 Years 1 Months | Current |
Ownership and Shareholding of Dev Anant Pharmaceutical Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Dev Anant Pharmaceutical Private Limited
Dev Anant Pharmaceutical Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Dev Anant Pharmaceutical Private Limited
Dev Anant Pharmaceutical Private Limited has a workforce of 0 employees as of Apr 09, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Dev Anant Pharmaceutical Private Limited
Dev Anant Pharmaceutical Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Gaurav Kumar Sharma was appointed as Director on 13 Aug 2020.
Credit Ratings, Litigation & Regulatory Alerts for Dev Anant Pharmaceutical Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Dev Anant Pharmaceutical Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Dev Anant Pharmaceutical Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Dev Anant Pharmaceutical Private Limited
Dev Anant Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAHCD9064D1ZI | Uttar Pradesh | Active | 10 Sep 2020 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Dev Anant Pharmaceutical Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dev Anant Pharmaceutical Private Limited
Dev Anant Pharmaceutical is an active private limited company based in Meerut, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 13 August 2020 (6+ years old) and is registered under CIN U24110UP2020PTC132637.
Dev Anant Pharmaceutical reported revenue of ₹5.61 Lakh for FY 2024 (up 88% YoY).
Dev Anant Pharmaceutical has 2 current directors:
- Munesh Kumar Sharma - Director
- Gaurav Kumar Sharma - Director
Dev Anant Pharmaceutical reported a net profit of ₹3,909 (net margin 0.7%) and EBITDA of ₹19,923 (EBITDA margin 3.6%) for FY 2024, as per its filed financial statements.
The GSTIN of Dev Anant Pharmaceutical is 09AAHCD9064D1ZI, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Dev Anant Pharmaceutical is U24110UP2020PTC132637. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dev Anant Pharmaceutical was incorporated on 13 August 2020, making it 6+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Dev Anant Pharmaceutical by revenue are Superlite Vinimay Private Limited, Kevin Biotech Private Limited, Palindrome Design India Private Limited, Luckwin Trademart Private Limited, Udhaarlo Private Limited and 5 more, all in the same principal business activity (Wholesale Trading).
Gaurav Kumar Sharma was appointed as Director on 13 Aug 2020. Munesh Kumar Sharma was appointed as Director on 13 Aug 2020.
The registered office of Dev Anant Pharmaceutical is at H 2834 Ganga Nagar Near Dadhichi Public School, Meerut, Uttar Pradesh, India – 250001.
Dev Anant Pharmaceutical has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh.